Nomura Holdings Inc ADR NMR
10.06
0.29
2.97%
as of 25 Sep
- Market cap
- $28.6B
- P/E
- 10.3×
Follow NMR
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.96 | — | 8.87 | 8.89 |
+8 more quarters Free account |
P/S ratio |
0.78 | — | 0.67 | 0.61 | |
P/FCF ratio |
4.79 | — | 4.00 | 0.00 | |
P/Operating CF |
3.99 | — | 3.33 | (7.91) | |
P/B ratio |
1.02 | — | 0.87 | 0.79 | |
Price to Tangible BV |
1.03 | — | 0.88 | 0.80 | |
EV/Sales |
(3.38) | — | 1.34 | 1.45 | |
EV/EBITDA |
0.00 | — | 1.79 | 1.94 | |
EV/Operating CF |
(18.88) | — | 7.31 | (29.62) | |
EV/FCF |
(20.76) | — | 8.04 | (21.15) | |
Quick Ratio |
1.75 | 0.89 | 0.91 | 0.91 | |
Current Ratio |
2.00 | 1.12 | 1.13 | 1.13 | |
Net Debt/EBITDA |
(22.31) | 0.00 | 3.77 | 4.52 | |
Debt/Assets |
47.17% | 46.45% | 46.10% | 46.83% | |
Debt/Equity |
8.06 | 7.54 | 7.71 | 7.58 | |
Asset Turnover |
0.08 | 0.00 | 0.16 | 0.08 | |
Operating CF/Net income |
0.00 | — | 10.24 | 0.00 | |
Capex/Depreciation |
— | — | 0.09 | — | |
Interest Coverage |
0.00 | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.78% | — | 23.39% | 22.43% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Graham Net Nets |
(0.04) | — | (7.68) | (8.35) | |
Graham Number |
13.79 | — | 12.41 | 11.78 | |
Earnings Yield |
11.16% | — | 11.28% | 11.25% | |
Free Cash Flow Yield |
20.86% | — | 25.01% | (11.15%) | |
Revenue per Share |
2.96 | — | 2.69 | 2.69 | |
Operating CF per Share |
0.00 | — | 2.18 | 0.00 | |
Capex per Share |
0.00 | — | 0.01 | 0.00 | |
Free Cash Flow per Share |
0.00 | — | 2.19 | 0.00 | |
Cash per Share |
116.30 | 0.00 | 57.07 | 54.24 | |
Shareholders Equity per Share |
8.63 | 0.00 | 8.35 | 8.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.63 | 0.00 | 8.35 | 8.33 | |
Free Cash Flow |
— | — | 6,430.43 | — | |
Working Capital |
201,692.60 | 22,835.80 | 25,213.20 | 24,445.10 | |
Capital Expenditures |
— | — | 19.28 | — | |
Net Current Asset Value |
(1,060.10) | (164,180.50) | (164,045.30) | (163,307.30) | |
EV/EBIT |
0.00 | — | 1.81 | 1.93 | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
10.61% | — | 7.93% | 9.04% | |
Price to Operating Income |
4.37 | — | 4.24 | 4.12 | |
| Other line items | |||||
Average Receivables |
11,688.03 | 9,371.48 | 9,906.05 | 9,448.31 | |
Average Payables |
32,506.05 | 30,995.17 | 30,009.61 | 28,223.03 | |
Average Assets |
414,654.15 | 393,775.70 | 205,250.20 | 390,706.60 | |
Average Common Equity |
24,708.05 | 23,775.32 | 23,671.67 | 24,279.25 |
Columns are period end dates